For research and educational purposes only. Not medical advice.
Methylene blue Reference
Educational, not medical advice reference for Methylene blue: Nootropic, Metabolic; regulatory status, evidence posture, source review, and schedule notes. A…
Reference summary
Methylene blue is label-verified for methemoglobinemia. Low-dose nootropic literature is preclinical and small human pilot trials.
- Categories
- Nootropic, Metabolic
- Aliases
- Provayblue, Methylthioninium chloride, Methylene blue USP
- Evidence posture
- human — FDA-approved at therapeutic doses for methemoglobinemia. Low-dose nootropic / cognitive use is off-label. Concomitant SSRIs / MAOIs / serotonergic agents can produce serotonin syndrome — methylene blue is a potent MAO-A inhibitor at therapeutic doses.
- Regulatory status
- FDA-approved prescription medication (Provayblue) for acquired methemoglobinemia. Low-dose nootropic / cognitive use is off-label. Not a controlled substance.
- Content review status
- label verified